Biotech company IRX Therapeutics, Inc., recently announced its plans to relocate from New York to St. Petersburg.
IRX develops therapies to treat cancer and infectious diseases, including IRX-2--an active immunotherapy that treats cancer by restoring the patient's immune system and enabling an immune attack on the tumor, according to
USF News.
IRX and the
Florida High Tech Corridor Council agreed to jointly fund $2.5 million in research at the University of South Florida.
Read the complete
story.
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.